https://www.selleckchem.com/pr....oducts/dorsomorphin-
PURPOSE To quantify the central visual field (VF) loss patterns in glaucoma using artificial intelligence. DESIGN Retrospective study. PARTICIPANTS VFs of 8712 patients with 13 951 Humphrey 10-2 test results from 13 951 eyes for cross-sectional analyses, and 824 patients with at least 5 reliable 10-2 test results at 6-month intervals or more from 1191 eyes for longitudinal analyses. METHODS Total deviation values were used to determine the central VF patterns using the most recent 10-2 test results. A 24-2 VF within a 3-month
Like
Comment
Share
